TN2011000380A1 - Triazolopyridine derivatives as p38 map kinase inhibitors - Google Patents
Triazolopyridine derivatives as p38 map kinase inhibitorsInfo
- Publication number
- TN2011000380A1 TN2011000380A1 TN2011000380A TN2011000380A TN2011000380A1 TN 2011000380 A1 TN2011000380 A1 TN 2011000380A1 TN 2011000380 A TN2011000380 A TN 2011000380A TN 2011000380 A TN2011000380 A TN 2011000380A TN 2011000380 A1 TN2011000380 A1 TN 2011000380A1
- Authority
- TN
- Tunisia
- Prior art keywords
- radical
- optionally substituted
- map kinase
- alkyl
- independently
- Prior art date
Links
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 title abstract 2
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 title abstract 2
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 title 1
- 150000008523 triazolopyridines Chemical class 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 abstract 1
- 241000042812 Divales Species 0.000 abstract 1
- -1 amino, hydroxyl Chemical group 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 125000006413 ring segment Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0902651A GB0902651D0 (en) | 2009-02-17 | 2009-02-17 | Pharmaceutical compounds and compositions |
GB0908069A GB0908069D0 (en) | 2009-05-11 | 2009-05-11 | Pharmaceutical compounds and compositions |
PCT/GB2010/050257 WO2010094956A1 (fr) | 2009-02-17 | 2010-02-16 | Dérivés de triazolopyridine utilisés comme inhibiteurs de la p38 map kinase |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2011000380A1 true TN2011000380A1 (en) | 2013-03-27 |
Family
ID=42232647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TN2011000380A TN2011000380A1 (en) | 2009-02-17 | 2011-08-03 | Triazolopyridine derivatives as p38 map kinase inhibitors |
Country Status (19)
Country | Link |
---|---|
US (1) | US8557797B2 (fr) |
EP (1) | EP2398798A1 (fr) |
JP (1) | JP2012517992A (fr) |
KR (1) | KR20110116030A (fr) |
CN (2) | CN103483338A (fr) |
AU (1) | AU2010215261A1 (fr) |
BR (1) | BRPI1005327A2 (fr) |
CA (1) | CA2752693A1 (fr) |
CL (1) | CL2011001977A1 (fr) |
CO (1) | CO6420344A2 (fr) |
EA (1) | EA201190119A1 (fr) |
IL (1) | IL214658A0 (fr) |
MA (1) | MA33128B1 (fr) |
MX (1) | MX2011008496A (fr) |
PE (1) | PE20120655A1 (fr) |
SG (1) | SG174134A1 (fr) |
TN (1) | TN2011000380A1 (fr) |
WO (1) | WO2010094956A1 (fr) |
ZA (1) | ZA201105993B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2212291B1 (fr) * | 2007-10-24 | 2014-06-04 | Merck Sharp & Dohme Corp. | Antagonistes de canaux calciques de type t à base de phényle amide hétérocyclique |
GB201009731D0 (en) * | 2010-06-10 | 2010-07-21 | Pulmagen Therapeutics Inflamma | Kinase inhibitors |
EP2736899A1 (fr) | 2011-07-26 | 2014-06-04 | Grünenthal GmbH | Dérivés de carboxamide et d'urée aromatiques bicycliques substitués en tant que ligands de récepteur de vanilloïde |
KR101994381B1 (ko) | 2011-12-09 | 2019-06-28 | 키에시 파르마슈티시 엣스. 피. 에이. | 키나아제 억제제 |
SG11201402986RA (en) * | 2011-12-09 | 2014-12-30 | Chiesi Farma Spa | Kinase inhibitors |
KR20140103925A (ko) | 2011-12-09 | 2014-08-27 | 키에시 파르마슈티시 엣스. 피. 에이. | 4-히드록시-1,2,3,4-테트라히드로나프탈렌-1-일 우레아 및 호흡기 질환의 치료에서의 이들의 용도 |
WO2014015056A2 (fr) | 2012-07-17 | 2014-01-23 | Washington University | Médicaments anti-mucus et leurs utilisations |
KR20160016973A (ko) * | 2013-06-06 | 2016-02-15 | 키에시 파르마슈티시 엣스. 피. 에이. | P38 - map 키나아제 억제제로서 [1, 2, 4] 트리아졸로 [4, 3 - a] 피리딘의 유도체 |
CN105377847A (zh) * | 2013-06-06 | 2016-03-02 | 奇斯药制品公司 | 激酶抑制剂 |
EP3004098B1 (fr) | 2013-06-06 | 2017-08-09 | Chiesi Farmaceutici S.p.A. | Inhibiteurs de kinase |
GB201321742D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
EA201790806A1 (ru) | 2014-11-05 | 2017-11-30 | Флексус Байосайенсиз, Инк. | Иммунорегулирующие средства |
UY36390A (es) | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen |
SG10202110259QA (en) | 2017-10-05 | 2021-10-28 | Fulcrum Therapeutics Inc | Use of p38 inhibitors to reduce expression of dux4 |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
WO1997002289A1 (fr) | 1995-07-06 | 1997-01-23 | Zeneca Limited | Inhibiteurs peptidiques de la fibronectine |
US6248713B1 (en) | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
YU25500A (sh) | 1999-05-11 | 2003-08-29 | Pfizer Products Inc. | Postupak za sintezu analoga nukleozida |
GB0028383D0 (en) | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
EP1241176A1 (fr) | 2001-03-16 | 2002-09-18 | Pfizer Products Inc. | Dérivés de purine pour le traitement de l'ischémie |
DE60214428T2 (de) | 2001-12-20 | 2007-09-20 | Bayer Healthcare Ag | 1, 4-dihydro-1, 4-diphenylpyridin-derivate |
WO2004072072A1 (fr) | 2003-02-14 | 2004-08-26 | Pfizer Products Inc. | Triazolo-pyridines utilisees comme composes anti-inflammatoires |
SE0302487D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
EP1751139B1 (fr) | 2004-04-30 | 2011-07-27 | Bayer HealthCare LLC | Derives de pyrazolyl uree substitues utiles dans le traitement du cancer |
EP1609789A1 (fr) | 2004-06-23 | 2005-12-28 | Eli Lilly And Company | Derives de ureido-pyrazole et leur utilisation comme inhibiteurs de kinase |
SI1761520T1 (sl) | 2004-06-23 | 2008-10-31 | Lilly Co Eli | Inhibitorji kinaze |
GB0418015D0 (en) * | 2004-08-12 | 2004-09-15 | Pfizer Ltd | New compounds |
PL1778686T3 (pl) | 2004-08-12 | 2009-04-30 | Pfizer | Pochodne triazolopirydynylosulfanylowe jako inhibitory kinazy MAP P38 |
JP2008509985A (ja) | 2004-08-18 | 2008-04-03 | ファルマシア アンド アップジョン カンパニー リミテッド ライアビリティ カンパニー | 炎症治療用の新規トリアゾロピリジン化合物 |
GB0502258D0 (en) | 2005-02-03 | 2005-03-09 | Argenta Discovery Ltd | Compounds and their use |
EP1984363A1 (fr) | 2006-02-09 | 2008-10-29 | Pfizer Limited | Composes triazolopyridine |
WO2008024746A1 (fr) | 2006-08-21 | 2008-02-28 | Array Biopharma, Inc. | Dérivés de l'acide phénoxyphénylacétique 4-substitué |
GB0902648D0 (en) | 2009-02-17 | 2009-04-01 | Argenta Discovery Ltd | Pharmaceutical compounds and compositions |
-
2010
- 2010-02-16 PE PE2011001509A patent/PE20120655A1/es not_active Application Discontinuation
- 2010-02-16 MX MX2011008496A patent/MX2011008496A/es not_active Application Discontinuation
- 2010-02-16 EP EP10704973A patent/EP2398798A1/fr not_active Withdrawn
- 2010-02-16 SG SG2011058823A patent/SG174134A1/en unknown
- 2010-02-16 BR BRPI1005327A patent/BRPI1005327A2/pt not_active IP Right Cessation
- 2010-02-16 JP JP2011549680A patent/JP2012517992A/ja active Pending
- 2010-02-16 EA EA201190119A patent/EA201190119A1/ru unknown
- 2010-02-16 CA CA2752693A patent/CA2752693A1/fr not_active Abandoned
- 2010-02-16 CN CN201310309129.6A patent/CN103483338A/zh active Pending
- 2010-02-16 US US13/201,716 patent/US8557797B2/en not_active Expired - Fee Related
- 2010-02-16 MA MA34175A patent/MA33128B1/fr unknown
- 2010-02-16 WO PCT/GB2010/050257 patent/WO2010094956A1/fr active Application Filing
- 2010-02-16 KR KR1020117018786A patent/KR20110116030A/ko not_active Application Discontinuation
- 2010-02-16 CN CN2010800078222A patent/CN102395586A/zh active Pending
- 2010-02-16 AU AU2010215261A patent/AU2010215261A1/en not_active Abandoned
-
2011
- 2011-08-03 TN TN2011000380A patent/TN2011000380A1/fr unknown
- 2011-08-12 CL CL2011001977A patent/CL2011001977A1/es unknown
- 2011-08-15 IL IL214658A patent/IL214658A0/en unknown
- 2011-08-16 ZA ZA2011/05993A patent/ZA201105993B/en unknown
- 2011-08-16 CO CO11103685A patent/CO6420344A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN103483338A (zh) | 2014-01-01 |
EP2398798A1 (fr) | 2011-12-28 |
PE20120655A1 (es) | 2012-06-07 |
CN102395586A (zh) | 2012-03-28 |
JP2012517992A (ja) | 2012-08-09 |
US20120088763A1 (en) | 2012-04-12 |
KR20110116030A (ko) | 2011-10-24 |
IL214658A0 (en) | 2011-09-27 |
CO6420344A2 (es) | 2012-04-16 |
ZA201105993B (en) | 2012-10-31 |
US8557797B2 (en) | 2013-10-15 |
WO2010094956A1 (fr) | 2010-08-26 |
MA33128B1 (fr) | 2012-03-01 |
AU2010215261A1 (en) | 2011-09-08 |
CL2011001977A1 (es) | 2011-11-18 |
EA201190119A1 (ru) | 2012-05-30 |
SG174134A1 (en) | 2011-10-28 |
MX2011008496A (es) | 2011-11-18 |
CA2752693A1 (fr) | 2010-08-26 |
BRPI1005327A2 (pt) | 2019-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2011000380A1 (en) | Triazolopyridine derivatives as p38 map kinase inhibitors | |
MX2012015023A (es) | Derivado novedoso de nicotinamida o sal del mismo. | |
MX2009002802A (es) | Derivados de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparacion y su aplicacion en terapeutica. | |
MY159239A (en) | Urea derivatives that are kinase inhibitors, and their therapeutic use | |
EA200970493A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
AR065556A1 (es) | Derivados de 3-(( 1,2,4) triazolo (4,3-a) piridin -7-il) benzamida | |
EA201791254A1 (ru) | Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета | |
GEP20156267B (en) | 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES | |
GEP20166484B (en) | Protein kinase inhibitors | |
EA201290260A1 (ru) | Бензимидазол-имидазольные производные | |
MX2010003445A (es) | Derivados de nicotinamida, su preparacion y su uso terapeutico. | |
EA201101566A1 (ru) | Производные имидазола и их применение в качестве модуляторов циклинзависимых киназ | |
EA201100115A1 (ru) | Новые производные аденина | |
RU2009125578A (ru) | Новые замещенные диазаспиропиридиноновые производные для применения в лечении мсн-1-опосредованных заболеваний | |
TW200716531A (en) | Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia | |
MX2010006202A (es) | Derivados de oxindol substituidos por amidometil y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
MX2010000658A (es) | Derivados de pirimidina 934. | |
MX2016006685A (es) | Compuestos heterociclicos de n-acilimino. | |
MX2022000854A (es) | Derivados de 2-morfolinopiridina sustituidos como inhibidores de la cinasa atr. | |
NO20085317L (no) | Imidazoazepinonforbindelser | |
DE602007001463D1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
AR057461A1 (es) | Derivados de pirazol, proceso de preparacion, composiciones farmaceuticas y usos | |
TW200602344A (en) | Novel pyrrolo(2, 3-b)pyridine derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | |
CO6321159A2 (es) | Compuestos pirazina fusionados utiles para el tratamiento de enfermedades degenerativas e inflamatorias | |
AR083861A1 (es) | OXAZOLIDINONAS COMO MODULADORES DE mGluR5 Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN |